C15ORF42 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.986400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.001400E-01
Normal-vs-Stage2
4.408600E-01
Normal-vs-Stage3
9.244200E-01
Normal-vs-Stage4
9.423600E-01
Stage1-vs-Stage2
4.286200E-01
Stage1-vs-Stage3
8.561400E-01
Stage1-vs-Stage4
6.928400E-01
Stage2-vs-Stage3
4.245800E-01
Stage2-vs-Stage4
3.423400E-01
Stage3-vs-Stage4
8.347000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.936400E-01
Normal-vs-AfricanAmerican
8.133800E-01
Normal-vs-Asian
4.260600E-01
Caucasian-vs-AfricanAmerican
5.233200E-01
Caucasian-vs-Asian
7.623200E-01
AfricanAmerican-vs-Asian
4.510800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.916000E-01
Normal-vs-Female
4.944000E-01
Male-vs-Female
3.165000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.559200E-01
Normal-vs-Age(41-60Yrs)
4.568800E-01
Normal-vs-Age(61-80Yrs)
4.716200E-01
Normal-vs-Age(81-100Yrs)
4.032400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.749400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.393790E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.387760E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.984000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.059800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.825000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.753000E-01
Normal-vs-Daily Drinker
4.938800E-01
Normal-vs-Weekly Drinker
4.538600E-01
Normal-vs-Occasional Drinker
4.416800E-01
Normal-vs-Social Drinker
4.272000E-01
Non Drinker-vs-Daily Drinker
3.560600E-01
Non Drinker-vs-Weekly Drinker
5.090000E-01
Non Drinker-vs-Occasional Drinker
5.722800E-01
Non Drinker-vs-Social Drinker
5.317200E-01
Daily Drinker-vs-Weekly Drinker
2.649800E-01
Daily Drinker-vs-Occasional Drinker
7.025800E-01
Daily Drinker-vs-Social Drinker
7.584800E-01
Weekly Drinker-vs-Occasional Drinker
3.386400E-01
Weekly Drinker-vs-Social Drinker
3.240400E-01
Occasional Drinker-vs-Social Drinker
9.471000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.527400E-01
Normal-vs-Grade 2
6.036000E-01
Normal-vs-Grade 3
6.230400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.610710E-04
Grade 1-vs-Grade 3
7.63740000000457E-05
Grade 1-vs-Grade 4
5.527400E-01
Grade 2-vs-Grade 3
2.388000E-01
Grade 2-vs-Grade 4
6.036000E-01
Grade 3-vs-Grade 4
6.230400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.076000E-01
Normal-vs-NonDiabetic
4.510800E-01
Diabetic-vs-NonDiabetic
6.536200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.000400E-01
Normal-vs-NoPancreatitis
5.526000E-01
Pancreatitis-vs-NoPancreatitis
1.965150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.986400E-01
Normal-vs-N1
4.679400E-01
N0-vs-N1
3.081800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.883050E-01
Normal-vs-TP53-NonMutant
6.126400E-01
TP53-Mutant-vs-TP53-NonMutant
7.53239999999877E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
